TickerFactsScreenerDevelopers

NEKTAR THERAPEUTICS (NKTR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: $39.74M2010: -$55.87M2011: -$113.74M2012: -$129.76M2013: -$38.53M2016: -$117.02M2017: -$80.41M2018: $718.21M2019: -$328.68M2020: -$313.29M2021: -$412.66M2022: -$304.01M2023: -$192.61M2024: -$175.71M2025: -$208.51M-$208.51M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$208.51M-18.7%
2024-$175.71M+8.8%
2023-$192.61M+36.6%
2022-$304.01M+26.3%
2021-$412.66M-31.7%
2020-$313.29M+4.7%
2019-$328.68M-145.8%
2018$718.21M+993.1%
2017-$80.41M+31.3%
2016-$117.02M—
2013-$38.53M+70.3%
2012-$129.76M-14.1%
2011-$113.74M-103.6%
2010-$55.87M-240.6%
2009$39.74M—